← Back to headlines
Truist Remains Bullish on Zymeworks
Truist maintains a bullish stance on Zymeworks (ZYME), explaining their continued positive outlook.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
U.S. Treasury Yields Surge as Fed Official Signals Support for Rate Hike
1h ago
Kalshi Permanently Bans George Santos Over Insider Trading on State of the Union Bets
1h ago
Dell Stock Gains Investor Focus Ahead of September Earnings Report
1h ago
Sony and Warner Music Sue Anthropic Over AI Training Copyright Claims
1h ago